LitCovid-sample-Enju  

PMC:7199903 / 947-1832 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T140 0-3 DT denotes The
T141 4-13 NN denotes emergence
T142 14-16 IN denotes of
T143 17-20 DT denotes the
T144 21-36 NN denotes betacoronavirus
T145 36-37 -COMMA- denotes ,
T146 38-44 JJ denotes severe
T147 45-50 JJ denotes acute
T148 51-62 JJ denotes respiratory
T149 63-71 NN denotes syndrome
T150 72-83 NN denotes coronavirus
T151 84-85 CD denotes 2
T152 86-87 -LRB- denotes (
T153 87-97 NN denotes SARS-CoV-2
T154 97-98 -RRB- denotes )
T155 98-99 -COMMA- denotes ,
T156 100-103 DT denotes the
T157 104-113 JJ denotes causative
T158 114-119 NN denotes agent
T159 120-122 IN denotes of
T160 123-134 NN denotes coronavirus
T161 135-142 NN denotes disease
T162 143-147 CD denotes 2019
T163 148-149 -LRB- denotes (
T164 149-157 NN denotes COVID-19
T165 157-158 -RRB- denotes )
T166 158-159 -COMMA- denotes ,
T167 160-170 VBZ denotes represents
T168 171-172 DT denotes a
T169 173-185 JJ denotes considerable
T170 186-192 NN denotes threat
T171 193-195 TO denotes to
T172 196-202 JJ denotes global
T173 203-208 JJ denotes human
T174 209-215 NN denotes health
T175 217-224 NN denotes Vaccine
T176 225-236 NN denotes development
T177 237-239 VBZ denotes is
T178 240-247 VBN denotes focused
T179 248-250 IN denotes on
T180 251-254 DT denotes the
T181 255-264 JJ denotes principal
T182 265-271 NN denotes target
T183 272-274 IN denotes of
T184 275-278 DT denotes the
T185 279-286 JJ denotes humoral
T186 287-293 JJ denotes immune
T187 294-302 NN denotes response
T188 302-303 -COMMA- denotes ,
T189 304-307 DT denotes the
T190 308-313 NN denotes spike
T191 314-315 -LRB- denotes (
T192 315-316 NN denotes S
T193 316-317 -RRB- denotes )
T194 318-330 NN denotes glycoprotein
T195 330-331 -COMMA- denotes ,
T196 332-337 WDT denotes which
T197 338-346 VBZ denotes mediates
T198 347-351 NN denotes cell
T199 352-357 NN denotes entry
T200 358-361 CC denotes and
T201 362-370 NN denotes membrane
T202 371-377 NN denotes fusion
T203 379-382 DT denotes The
T204 383-393 NN denotes SARS-CoV-2
T205 394-395 NN denotes S
T206 396-400 NN denotes gene
T207 401-408 VBZ denotes encodes
T208 409-411 CD denotes 22
T209 412-420 JJ denotes N-linked
T210 421-427 NN denotes glycan
T211 428-435 NNS denotes sequons
T212 436-439 IN denotes per
T213 440-448 NN denotes protomer
T214 448-449 -COMMA- denotes ,
T215 450-455 WDT denotes which
T216 456-462 RB denotes likely
T217 463-467 VBP denotes play
T218 468-469 DT denotes a
T219 470-474 NN denotes role
T220 475-477 IN denotes in
T221 478-485 NN denotes protein
T222 486-493 NN denotes folding
T223 494-497 CC denotes and
T224 498-504 JJ denotes immune
T225 505-512 NN denotes evasion
T226 514-518 RB denotes Here
T227 518-519 -COMMA- denotes ,
T228 520-525 VBG denotes using
T229 526-527 DT denotes a
T230 528-541 JJ denotes site-specific
T231 542-546 NN denotes mass
T232 547-560 JJ denotes spectrometric
T233 561-569 NN denotes approach
T234 569-570 -COMMA- denotes ,
T235 571-573 PRP denotes we
T236 574-580 VBP denotes reveal
T237 581-584 DT denotes the
T238 585-591 NN denotes glycan
T239 592-602 NNS denotes structures
T240 603-605 IN denotes on
T241 606-607 DT denotes a
T242 608-619 JJ denotes recombinant
T243 620-630 NN denotes SARS-CoV-2
T244 631-632 NN denotes S
T245 633-642 NN denotes immunogen
T246 644-648 DT denotes This
T247 649-657 NN denotes analysis
T248 658-665 VBZ denotes enables
T249 666-673 NN denotes mapping
T250 674-676 IN denotes of
T251 677-680 DT denotes the
T252 681-698 NN denotes glycan-processing
T253 699-705 NNS denotes states
T254 706-712 IN denotes across
T255 713-716 DT denotes the
T256 717-725 JJ denotes trimeric
T257 726-731 JJ denotes viral
T258 732-737 NN denotes spike
T259 739-741 PRP denotes We
T260 742-746 VBP denotes show
T261 747-750 WRB denotes how
T262 751-761 JJ denotes SARS-CoV-2
T263 762-763 NN denotes S
T264 764-771 NNS denotes glycans
T265 772-778 VBP denotes differ
T266 779-783 IN denotes from
T267 784-791 JJ denotes typical
T268 792-796 NN denotes host
T269 797-803 NN denotes glycan
T270 804-814 NN denotes processing
T271 814-815 -COMMA- denotes ,
T272 816-821 WDT denotes which
T273 822-825 MD denotes may
T274 826-830 VB denotes have
T275 831-843 NNS denotes implications
T276 844-846 IN denotes in
T277 847-852 JJ denotes viral
T278 853-865 NN denotes pathobiology
T279 866-869 CC denotes and
T280 870-877 NN denotes vaccine
T281 878-884 NN denotes design
R142 T141 T140 arg1Of emergence,The
R143 T141 T142 arg1Of emergence,of
R144 T144 T142 arg2Of betacoronavirus,of
R145 T144 T143 arg1Of betacoronavirus,the
R146 T144 T145 arg1Of betacoronavirus,","
R147 T150 T145 arg2Of coronavirus,","
R148 T150 T146 arg1Of coronavirus,severe
R149 T150 T147 arg1Of coronavirus,acute
R150 T150 T148 arg1Of coronavirus,respiratory
R151 T150 T149 arg1Of coronavirus,syndrome
R152 T150 T151 arg1Of coronavirus,2
R153 T150 T152 arg1Of coronavirus,(
R154 T153 T152 arg2Of SARS-CoV-2,(
R155 T154 T152 arg3Of ),(
R156 T141 T155 arg1Of emergence,","
R157 T158 T155 arg2Of agent,","
R158 T158 T156 arg1Of agent,the
R159 T158 T157 arg1Of agent,causative
R160 T158 T159 arg1Of agent,of
R161 T161 T159 arg2Of disease,of
R162 T161 T160 arg1Of disease,coronavirus
R163 T161 T162 arg1Of disease,2019
R164 T161 T163 arg1Of disease,(
R165 T164 T163 arg2Of COVID-19,(
R166 T165 T163 arg3Of ),(
R167 T167 T166 arg1Of represents,","
R168 T141 T167 arg1Of emergence,represents
R169 T170 T167 arg2Of threat,represents
R170 T170 T168 arg1Of threat,a
R171 T170 T169 arg1Of threat,considerable
R172 T170 T171 arg1Of threat,to
R173 T174 T171 arg2Of health,to
R174 T174 T172 arg1Of health,global
R175 T174 T173 arg1Of health,human
R176 T176 T175 arg1Of development,Vaccine
R177 T176 T177 arg1Of development,is
R178 T178 T177 arg2Of focused,is
R179 T176 T178 arg2Of development,focused
R180 T178 T179 arg1Of focused,on
R181 T182 T179 arg2Of target,on
R182 T182 T180 arg1Of target,the
R183 T182 T181 arg1Of target,principal
R184 T182 T183 arg1Of target,of
R185 T187 T183 arg2Of response,of
R186 T187 T184 arg1Of response,the
R187 T187 T185 arg1Of response,humoral
R188 T187 T186 arg1Of response,immune
R189 T187 T188 arg1Of response,","
R190 T194 T188 arg2Of glycoprotein,","
R191 T194 T189 arg1Of glycoprotein,the
R192 T194 T190 arg1Of glycoprotein,spike
R193 T190 T191 arg1Of spike,(
R194 T192 T191 arg2Of S,(
R195 T193 T191 arg3Of ),(
R196 T182 T195 arg1Of target,","
R197 T182 T196 arg1Of target,which
R198 T182 T197 arg1Of target,mediates
R199 T200 T197 arg2Of and,mediates
R200 T199 T198 arg1Of entry,cell
R201 T199 T200 arg1Of entry,and
R202 T202 T200 arg2Of fusion,and
R203 T202 T201 arg1Of fusion,membrane
R204 T206 T203 arg1Of gene,The
R205 T206 T204 arg1Of gene,SARS-CoV-2
R206 T206 T205 arg1Of gene,S
R207 T206 T207 arg1Of gene,encodes
R208 T211 T207 arg2Of sequons,encodes
R209 T211 T208 arg1Of sequons,22
R210 T211 T209 arg1Of sequons,N-linked
R211 T211 T210 arg1Of sequons,glycan
R212 T211 T212 arg1Of sequons,per
R213 T213 T212 arg2Of protomer,per
R214 T211 T214 arg1Of sequons,","
R215 T211 T215 arg1Of sequons,which
R216 T217 T216 arg1Of play,likely
R217 T211 T217 arg1Of sequons,play
R218 T219 T217 arg2Of role,play
R219 T219 T218 arg1Of role,a
R220 T217 T220 arg1Of play,in
R221 T223 T220 arg2Of and,in
R222 T222 T221 arg1Of folding,protein
R223 T222 T223 arg1Of folding,and
R224 T225 T223 arg2Of evasion,and
R225 T225 T224 arg1Of evasion,immune
R226 T236 T226 arg1Of reveal,Here
R227 T236 T227 arg1Of reveal,","
R228 T235 T228 arg1Of we,using
R229 T233 T228 arg2Of approach,using
R230 T236 T228 modOf reveal,using
R231 T233 T229 arg1Of approach,a
R232 T233 T230 arg1Of approach,site-specific
R233 T233 T231 arg1Of approach,mass
R234 T233 T232 arg1Of approach,spectrometric
R235 T236 T234 arg1Of reveal,","
R236 T235 T236 arg1Of we,reveal
R237 T239 T236 arg2Of structures,reveal
R238 T239 T237 arg1Of structures,the
R239 T239 T238 arg1Of structures,glycan
R240 T236 T240 arg1Of reveal,on
R241 T245 T240 arg2Of immunogen,on
R242 T245 T241 arg1Of immunogen,a
R243 T245 T242 arg1Of immunogen,recombinant
R244 T245 T243 arg1Of immunogen,SARS-CoV-2
R245 T245 T244 arg1Of immunogen,S
R246 T247 T246 arg1Of analysis,This
R247 T247 T248 arg1Of analysis,enables
R248 T249 T248 arg2Of mapping,enables
R249 T249 T250 arg1Of mapping,of
R250 T253 T250 arg2Of states,of
R251 T253 T251 arg1Of states,the
R252 T253 T252 arg1Of states,glycan-processing
R253 T253 T254 arg1Of states,across
R254 T258 T254 arg2Of spike,across
R255 T258 T255 arg1Of spike,the
R256 T258 T256 arg1Of spike,trimeric
R257 T258 T257 arg1Of spike,viral
R258 T259 T260 arg1Of We,show
R259 T261 T260 arg2Of how,show
R260 T265 T261 arg1Of differ,how
R261 T264 T262 arg1Of glycans,SARS-CoV-2
R262 T264 T263 arg1Of glycans,S
R263 T264 T265 arg1Of glycans,differ
R264 T265 T266 arg1Of differ,from
R265 T270 T266 arg2Of processing,from
R266 T270 T267 arg1Of processing,typical
R267 T270 T268 arg1Of processing,host
R268 T270 T269 arg1Of processing,glycan
R269 T270 T271 arg1Of processing,","
R270 T270 T272 arg1Of processing,which
R271 T270 T273 arg1Of processing,may
R272 T274 T273 arg2Of have,may
R273 T270 T274 arg1Of processing,have
R274 T275 T274 arg2Of implications,have
R275 T274 T276 arg1Of have,in
R276 T279 T276 arg2Of and,in
R277 T278 T277 arg1Of pathobiology,viral
R278 T278 T279 arg1Of pathobiology,and
R279 T281 T279 arg2Of design,and
R280 T281 T280 arg1Of design,vaccine